The Anti-Diabetes Drugs market in Lesotho has been developing at a steady pace in recent years.
Customer preferences: The demand for Anti-Diabetes Drugs in Lesotho has been increasing due to the rising prevalence of diabetes among the population. The majority of the population in Lesotho lives in rural areas, where access to healthcare facilities is limited. As a result, many people with diabetes rely on medication to manage their condition.
Trends in the market: The Anti-Diabetes Drugs market in Lesotho has been growing due to the increasing prevalence of diabetes in the country. The market is dominated by multinational pharmaceutical companies that offer a range of products to treat diabetes. The market is also characterized by the availability of generic drugs, which are often cheaper than branded drugs. However, the quality of generic drugs is often a concern for patients.
Local special circumstances: Lesotho is a small, landlocked country in Southern Africa with a population of approximately 2 million people. The country has a high prevalence of diabetes, with an estimated 10% of the population affected by the disease. The healthcare system in Lesotho is under-resourced, and access to healthcare services is limited, particularly in rural areas.
Underlying macroeconomic factors: The economy of Lesotho is heavily dependent on agriculture, with the majority of the population engaged in subsistence farming. The country is also highly dependent on foreign aid, which accounts for a significant proportion of government revenue. The high prevalence of diabetes in Lesotho is a major public health concern, and the government has implemented a number of measures to address the issue, including the provision of free diabetes medication to patients. However, the availability and affordability of medication remain major challenges in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
